| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 6.019 | 1.401 | 834 | 58.815 | 22.658 | 5.822 | 9.801 | 15.808 | 3.191 |
| Total Income - EUR | 9.026 | 9.532 | 7.333 | 3.794 | 63.583 | 23.335 | 14.285 | 18.290 | 26.399 | 3.191 |
| Total Expenses - EUR | 10.728 | 9.390 | 14.219 | 8.372 | 8.335 | 1.126 | 11.522 | 6.282 | 21.750 | 10.824 |
| Gross Profit/Loss - EUR | -1.701 | 142 | -6.886 | -4.577 | 55.248 | 22.210 | 2.762 | 12.009 | 4.649 | -7.633 |
| Net Profit/Loss - EUR | -1.701 | 72 | -6.930 | -4.586 | 53.428 | 21.530 | 2.609 | 11.733 | 3.938 | -7.633 |
| Employees | 2 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 2 |
Check the financial reports for the company - Patisense Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.839 | 12.415 | 5.674 | 2.929 | 0 | 0 | 0 | 0 | 1.950 | 80.766 |
| Current Assets | 7.071 | 3.716 | 6.113 | 3.529 | 29.545 | 48.765 | 47.562 | 59.698 | 33.231 | 71.134 |
| Inventories | 0 | 135 | 2.483 | 0 | 0 | 0 | 481 | 0 | 1.461 | 11.154 |
| Receivables | 7.042 | 3.563 | 3.503 | 3.438 | 11.401 | 28.685 | 8.071 | 14.691 | 15.370 | 53.376 |
| Cash | 29 | 19 | 127 | 91 | 18.145 | 20.081 | 39.009 | 45.007 | 16.401 | 6.604 |
| Shareholders Funds | -15.156 | -16.365 | -23.019 | -32.367 | 21.687 | 42.806 | 44.466 | 56.336 | 31.537 | 23.735 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.594 | 32.497 | 28.056 | 35.161 | 7.168 | 5.959 | 3.096 | 3.362 | 3.644 | 87.961 |
| Income in Advance | 13.471 | 9.821 | 6.749 | 3.664 | 690 | 0 | 0 | 0 | 0 | 40.203 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Patisense Srl